Butrans" Approved by FDA for Pain Management
Links shared publicly online about this topic.
- 1,039total visits
Butrans" Approved by FDA for Pain Management
View full resource at hcplive.com
Tags: Pain Management, Pain, FDA
Most Recently Shared on July 7, 2010 at 4:11 pm By:
Butransâ„¢ Approved by FDA for Pain Management http://hcp.lv/9akcMt
A Marijuana-Based Spray for Pain Treatment Seeks FDA Approval - Pain Management Center - Everyday Health
everydayhealth.com — “A British company has submitted the first drug developed from marijuana for FDA approval. Will Sativex help to open up the debate about medical marijuana?” View full resource at everydayhealth.com
Most Recently Shared on January 27, 2012 at 1:00 pm By:
Pain Center of AZ Physician Group
Did you see this article about a #marijuana based spray for chronic pain? http://t.co/gLsuLwaW Would you use it if it gets approved?
Approval of New Fast-acting Fentanyl Formulations Offers Relief to Patients Suffering from Breakthrough Pain
painlive.com — “Approval of New Fast-acting Fentanyl Formulations Offers Relief to Patients Suffering from Breakthrough Pain” View full resource at painlive.com
Most Recently Shared on January 4, 2012 at 2:55 pm By:
Approval of New Fast-acting Fentanyl Formulations Offers Relief to Patients Suffering from Breakthrough Pain http://t.co/lyoqxo9G
RACKSPACE Medical News: Neurostimulator Okayed for Chronic Pain - in Pain Management, Pain Management from MedPage Today
medpagetoday.com — “The FDA has approved a Medtronic neurostimulation system for treating chronic back and leg pain that incorporates motion-sensor technology that adjusts the timing and level of stimulation according to” View full resource at medpagetoday.com
Most Recently Shared on November 22, 2011 at 3:41 am By:
sierra farris pa-c Physician Assistant
Neurostimulator Okayed for Chronic Pain - in Pain Management, Pain Management http://t.co/nSnPhWzN from @medpagetoday
Medtronic Receives FDA Approval of AdaptiveStim™ with RestoreSensor™ for the Management of Chronic Pain | Business Wire
businesswire.com — “Medtronic, Inc. (NYSE: MDT) today announced the U.S. Food & Drug Administration (FDA) approval of its AdaptiveStim™ with RestoreSensor&t” View full resource at businesswire.com
Most Recently Shared on November 17, 2011 at 6:50 pm By:
Medtronic Receives FDA Approval of AdaptiveStim™ with RestoreSensor™ for the Management of Chronic Pain: MINNEAP... http://t.co/f0dQLeMN
Pacira Pharmaceuticals, Inc. Announces U.S. FDA Approval of Exparel For Postsurgical Pain Management
drugs.com — “Exparel (bupivacaine liposome injectable suspension) is used for postsurgical pain management. Includes Exparel side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 31, 2011 at 5:28 pm By:
Pacira Pharmaceuticals, Inc. Announces U.S. FDA Approval of Exparel for Postsurgical Pain Management - http://t.co/TlSLEPVi
Exparel Approved for Postsurgical Pain Management - MPR
empr.com — “Pacira Pharmaceuticals announced that the FDA has approved Exparel (bupivacaine liposome injectable suspension) for administration into the surgical site to produce postsurgical analgesia.” View full resource at empr.com
Most Recently Shared on October 31, 2011 at 2:13 pm By:
Exparel Approved for Postsurgical Pain Management http://t.co/VmFuHkW4 #painmanagement
McKesson to Administer Cephalon Programs for Cancer Pain | News & Analysis
beckershospitalreview.com — “Cephalon, a Woodlands, Texas, medical device company, has chosen McKesson Specialty Health to administer its FDA-approved FENTORA and ACIQ Risk Evaluation and Mitigation Strategy Programs for management breakthrough pain in cancer patients” View full resource at beckershospitalreview.com
Most Recently Shared on October 19, 2011 at 7:15 pm By:
RelayHealth Health Business and Health IT
McKesson to Administer Cephalon Programs for Cancer Pain | News & Analysis http://t.co/j3O4YWiz
Medical News: Extended-Release Opioid Gets FDA OK - in Neurology, Pain Management from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved tapentadol (Nucynta), an extended-release oral opioid, to treat severe chronic pain.” View full resource at medpagetoday.com
Most Recently Shared on August 30, 2011 at 10:24 pm By:
Roger D. Jones, PhD Health Executive, Health Social Media, PhD, and Doctor
Medical News: Extended-Release Opioid Gets FDA OK - http://t.co/wbjQo31 from @medpagetoday #health #medicine
NUCYNTA® ER (Tapentadol Extended-Release Tablets) Receives FDA Approval For The Management Of Moderate To Severe Chronic Pain
jnj.com — “Johnson & Johnson news and information regarding our operations, products, leaders, and our charitable giving.” View full resource at jnj.com
Most Recently Shared on August 29, 2011 at 1:49 pm By:
eyeonfda Health Lawyer and Pharma
NUCYNTA® ER (Tapentadol ER) Gets #FDA Approval 4 Management Of Moderate To Severe Chronic Pain http://ow.ly/6fqQe
Nucynta ER (Tapentadol Extended-Release Tablets) Receives FDA Approval for the Management of Moderate to Severe Chronic Pain
drugs.com — “Nucynta ER (tapentadol) is used to treat moderate to severe acute pain. Includes Nucynta ER side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 26, 2011 at 10:17 pm By:
FDA Approves Nucynta ER for the Management of Moderate to Severe Chronic Pain - http://t.co/QwYR6Me
Medical News: Extended-Release Opioid Gets FDA OK - in Neurology, Pain Management from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved tapentadol (Nucynta), an extended-release oral opioid, to treat severe chronic pain.” View full resource at medpagetoday.com
Most Recently Shared on August 26, 2011 at 8:13 pm By:
Patricia Grace Eldercare Expert
Extended-Release Opioid Gets FDA Okay: WASHINGTON (MedPage Today) -- The FDA has approved tapentadol (Nucynta), ... http://t.co/n8lNnSE
Medical News: Extended-Release Opioid Gets FDA OK - in Neurology, Pain Management from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved tapentadol (Nucynta), an extended-release oral opioid, to treat severe chronic pain.” View full resource at medpagetoday.com
Most Recently Shared on August 26, 2011 at 7:55 pm By:
Extended-Release Opioid Gets FDA Okay http://t.co/JcIPno2
Medical News: Extended-Release Opioid Gets FDA OK - in Neurology, Pain Management from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved tapentadol (Nucynta), an extended-release oral opioid, to treat severe chronic pain.” View full resource at medpagetoday.com
Most Recently Shared on August 26, 2011 at 7:54 pm By:
Extended-Release Opioid Gets FDA Okay: WASHINGTON (MedPage Today) -- The FDA has approved… http://t.co/i3Zm69L
Nucynta ER Approved for Chronic Pain - MPR
empr.com — “Janssen Pharmaceuticals announced that the FDA has approved Nucynta ER (tapentadol extended-release) tablets for the management of moderate-to-severe chronic pain in adults when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.” View full resource at empr.com
Most Recently Shared on August 26, 2011 at 7:51 pm By:
Nucynta ER Approved for Chronic Pain http://ow.ly/6dYFZ #nucynta
PharmaLive: Nucynta ER (Tapentadol Extended-Release Tablets) Receives FDA Approval for the Management of Moderate to Severe Chronic Pain
pharmalive.com — “PharmaLive: Nucynta ER (Tapentadol Extended-Release Tablets) Receives FDA Approval for the Management of Moderate to Severe Chronic Pain” View full resource at pharmalive.com
Most Recently Shared on August 26, 2011 at 6:26 pm By:
PharmaLive Pharma and Health News
FDA OKs J&J's Nucynta ER - http://t.co/ye6i4zm
Advertisement
